Randomized, multicenter, phase III study of accelerated fraction radiotherapy with concomitant boost to the gross tumor volume compared with conventional fractionation in concurrent chemoradiation in patients with unresectable stage III non-small cell lung cancer: the Korean Radiation Oncology Group 09-03 trial.
International journal of radiation oncology, biology, physics（2022）
摘要
This clinical trial did not confirm the superiority of accelerated 2.4 Gy hypofractionated RT compared to conventional 2 Gy fractionation in patients with unresectable stage III NSCLC undergoing concurrent chemoradiation therapy.
更多查看译文
关键词
accelerated hypofractionated radiotherapy,concurrent chemoradiation therapy,non-small cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要